Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Whole-Body<sup>18</sup>F Dopa PET for Detection of Gastrointestinal Carcinoid Tumors
268
Zitationen
8
Autoren
2001
Jahr
Abstract
18F dopa PET is a promising procedure and useful supplement to morphologic methods in diagnostic imaging of gastrointestinal carcinoid tumors.
Ähnliche Arbeiten
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
2013 · 6.585 Zit.
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis
2016 · 4.998 Zit.
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2008 · 4.500 Zit.
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 · 4.190 Zit.
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 · 3.850 Zit.